Skandinaviska Enskilda Banken (SEB)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-22,803
Closed -$490K 916
2022
Q2
$490K Buy
22,803
+10,748
+89% +$298K ﹤0.01% 813
2022
Q1
$446K Sell
12,055
-5,982
-33% -$233K ﹤0.01% 846
2021
Q4
$815K Hold
18,037
﹤0.01% 799
2021
Q3
$1.14M Sell
18,037
-2,953
-14% -$225K 0.01% 766
2021
Q2
$1.92M Buy
20,990
+589
+3% +$46.8K 0.01% 677
2021
Q1
$1.39M Sell
20,401
-10,886
-35% -$845K 0.01% 754
2020
Q4
$2.27M Buy
+31,287
New +$1.81M 0.02% 606

Other funds holding CDNA

Skandinaviska Enskilda Banken (SEB)'s CDNA Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of CareDx (CDNA) in Q3 2022, closing a stake of 22,803 shares — an estimated $490K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CDNA in Q4 2020 and held it in 7 quarters. The position peaked at $2.27M in Q4 2020. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 22,803 CareDx shares in Q3 2022, an estimated $490K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in CareDx in Q4 2020 and held it in 7 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s CareDx position peaked at $2.27M in Q4 2020.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.